AKMV Consultants: Supporting Live M&A Mandates Across Sectors
Supported live M&A and fundraising mandates across logistics, pharma, and surveillance tech, building valuation models and profiling institutional investors.

Arpit Tevatia
Founder's Office at Propacity




From their time as

Finance Intern
AKMV Consultants • 2025 - 2025
Overview
Arpit joined AKMV Consultants as a Finance Intern and was placed directly on live M&A and fundraising mandates from day one. The work spanned three sectors: logistics, pharma, and surveillance technology.
The Story
Arpit joined AKMV Consultants as a Finance Intern and was placed directly on live M&A and fundraising mandates from day one. The work spanned three sectors: logistics, pharma, and surveillance technology.
His primary contribution was investor research and outreach support for two M&A transactions worth ₹300Cr+. He identified, profiled, and engaged with 25+ institutional investors, including PE funds, REITs, and sovereign funds, matching investor appetite to deal characteristics.
Alongside investor work, he built valuation models using EV/Revenue and EV/EBITDA benchmarks, running multiple scenarios to support deal pricing discussions. He also prepared investor-facing documents including teasers, investment memos, and outreach notes.
One of the mandates involved a last-mile logistics company operating across 600+ cities. For this deal, Arpit contributed to due diligence and synergy analysis, evaluating operational improvements and potential cost savings that could be realized post-acquisition.
He also prepared a sector research brief for the transport and logistics industry to support the M&A mandate. The brief drew on reports from BCG and Deloitte, company annual reports, government data, and competitor analysis. Rather than presenting all the information he gathered, he distilled the findings into a concise memo focused on market growth, industry fragmentation, technology adoption, and margin drivers, giving the deal team a clear narrative for investor discussions.
When the team wanted to include data points that did not materially support the investment case, Arpit recommended moving them to an appendix or removing them, backing his view with evidence rather than opinion.
